Long Term Follow-Up of MRD Guided Treatment of Ibrutinib Plus Venetoclax for Relapsed CLL: Phase 2 VISION/HO141 Trial.
Carsten Utoft Niemann, Julie Dubois,Kazem Nasserinejad, Caspar da Cunha-Bang, Sabina Kersting, Lisbeth Enggaard, Gerrit-Jan Veldhuis, Rogier Mous,Clemens H M Mellink, Anne-Marie F van der Kevie-Kersemaekers, Johan A Dobber, Christian Bjørn Poulsen, Wida Razawy, Rene Hollestein,Henrik Frederiksen,Ann Janssens,Ida Schjødt, Ellen C Dompeling, Juha Ranti,Christian Brieghel,Mattias Mattsson, Mar Bellido, T, Arnon P Kater, Mark-David Levin Blood advances（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper